BAUSCH HEALTH COMPAN

BHC
Delayed Quote. Delayed  - 04/09 04:10:00 pm
30.78USD +0.03%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2020 2021
Net sales1 8 0278 706
EBITDA1 3 2943 460
Operating profit (EBIT)1 2 9593 160
Operating Margin 36,9%36,3%
Pre-Tax Profit (EBT)1 -93472,5
Net income1 -560-34,8
Net margin -6,98%-0,40%
EPS2 -1,58-0,04
Dividend per Share2 --
Last update 02/24/202103/24/2021
1 USD in Million
2 USD
Estimates
Finances - Leverage
Fiscal Period: December 2020 2021
Net Debt1 22 10921 715
Net Cash position1 --
Leverage (Debt / EBITDA) 6,71x6,28x
Free Cash Flow1 8092 495
ROE (Net Profit / Equities) 179%299%
Shareholders' equity1 -313-11,7
ROA (Net Profit / Asset) 4,39%5,40%
Assets1 -12 757-645
Book Value Per Share2 1,512,14
Cash Flow per Share2 3,131,04
Capex1 302277
Capex / Sales 3,76%3,18%
Last update 02/24/202104/09/2021
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Financial Ratios
Size 2021e 2022e
Capitalization 10 947 M $ -
Entreprise Value (EV) 32 662 M $ 31 216 M $
Valuation 2021e 2022e
P/E ratio (Price / EPS) -700x 31,5x
Capitalization / Revenue 1,26x 1,21x
EV / Revenue 3,75x 3,61x
EV / EBITDA 9,44x 8,89x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 14,4x 8,12x
Profitability 2021e 2022e
Operating Margin (EBIT / Sales) 36,3% 37,3%
Operating Leverage (Delta EBIT / Delta Sales) 0,80x 1,74x
Net Margin (Net Profit / Revenue) -0,40% 2,68%
ROA (Net Profit / Asset) 5,40% 7,08%
ROE (Net Profit / Equities) 299% 170%
Rate of Dividend - -
Balance Sheet Analysis 2021e 2022e
CAPEX / Sales   3,18% 2,90%
Cash Flow / Sales 4,24% 19,8%
Capital Intensity (Assets / Sales) -0,07x 0,38x
Financial Leverage (Net Debt / EBITDA) 6,28x 5,52x
Price Earning Ratio
EPS & Dividend